NGL Fine Chem Ltd Stock Price Today (NSE: NGLFINE)
Fundamental Score
NGL Fine Chem Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
NGL Fine Chem Ltd share price today is ₹2057.10, down 5.32% on NSE/BSE as of 30 March 2026. NGL Fine Chem Ltd (NGLFINE) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹833.93 (Cr). The 52-week high for NGLFINE share price is ₹2575.00 and the 52-week low is ₹980.00. At a P/E ratio of 40.31x, NGLFINE is currently trading above its industry average P/E of 31.77x. The company has a Return on Equity (ROE) of 7.75% and a debt-to-equity ratio of 0.29.
NGL Fine Chem Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
NGL Fine Chem Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
NGL Fine Chem Share Price: A Financial Analysis for Strategic Growth
In the dynamic pharmaceutical industry, where innovation and regulatory compliance are paramount, understanding individual stock performance requires careful analysis. This financial analysis delves into the "NGL Fine Chem share price" and its key financial metrics. Currently trading at ₹2190.39990234375, NGL Fine Chem Ltd presents an interesting case for potential investors and industry observers. This analysis is part of a comprehensive 80-parameter fundamental audit verified by Sweta Mishra.
The Price-to-Earnings (PE) ratio of 40.31 suggests a relatively high valuation compared to some broader market averages, indicating market expectations of future growth. However, to contextualize this, we need to compare it to its peers. For example, while we will avoid direct quality rankings, it is useful to observe how
Mankind Pharma Ltd manages capital allocation and shareholder returns. Such observations can help assess the market's perception of NGL Fine Chem's management quality, though the PE ratio alone is insufficient for drawing definitive conclusions.A critical factor in evaluating NGL Fine Chem's long-term viability is its Return on Capital Employed (ROCE) of 9.44%. While positive, this figure suggests there is scope for improvement in capital efficiency. ROCE is a key determinant of a company's ability to create a sustainable economic moat. A higher ROCE would signify a stronger ability to reinvest profits and generate superior returns compared to competitors like Smruthi Organics Ltd and Balaxi Pharmaceuticals Ltd, ultimately enhancing its competitive advantage and driving long-term value creation. A more robust ROCE contributes significantly to building a defensible market position.
Ultimately, further investigation into revenue growth, debt levels, and competitive positioning within its specific niche is necessary to gain a more complete understanding of NGL Fine Chem Ltd's financial health and the factors influencing its share price. This analysis presents observations based on publicly available data and does not constitute financial advice. Potential investors should conduct their own due diligence.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
NGL Fine Chem Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NGLFINE across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Operating Margins (17.42%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (28.65%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (19.41% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (16.89% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (16.89% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Conservative Debt Levels (D/E: 0.29)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (7.87x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.74%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Below-Average Return on Equity (7.75%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (9.44%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 40.31x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Negative Free Cash Flow (₹-45.98 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
NGL Fine Chem Ltd Financial Statements
Comprehensive financial data for NGL Fine Chem Ltd including income statement, balance sheet and cash flow
About NGLFINE (NGL Fine Chem Ltd)
NGL Fine Chem Ltd is a dynamic player in the pharmaceutical landscape, specializing in the development and manufacturing of high-quality active pharmaceutical ingredients (APIs) an...d advanced intermediates. With a strong emphasis on innovation, NGLFINE caters to both the veterinary and human health sectors, serving as a reliable partner for pharmaceutical companies worldwide. The company's commitment to rigorous quality standards and cutting-edge technology ensures the consistent production of safe and effective products, contributing to improved health outcomes for both animals and humans. NGLFINE operates with a global perspective, serving clients across diverse markets through strategic partnerships and a robust supply chain network. NGLFINE distinguishes itself through a comprehensive portfolio of specialized APIs tailored to address critical health needs. In the veterinary arena, NGLFINE offers a range of antiparasitic and therapeutic compounds designed to combat common animal ailments, enhancing livestock health and productivity. For human health applications, NGLFINE provides crucial ingredients for a variety of pharmaceutical formulations, focusing on areas where unmet needs exist. The company's focus extends beyond manufacturing, as it actively invests in research and development to expand its product offerings and explore novel therapeutic solutions. This dedication to innovation positions NGLFINE at the forefront of the pharmaceutical industry, driving advancements in healthcare. NGLFINE is deeply committed to environmental sustainability and ethical business practices. The company operates with a responsible approach, implementing measures to minimize environmental impact throughout its manufacturing processes. By adhering to stringent regulatory guidelines and prioritizing workplace safety, NGLFINE fosters a culture of integrity and accountability. This commitment extends to its relationships with customers, suppliers, and the communities in which it operates, fostering trust and long-term partnerships. NGLFINE's dedication to quality, innovation, and sustainability underscores its mission to improve global health while operating responsibly.
Company Details
Key Leadership
Corporate Events
NGLFINE Share Price: Frequently Asked Questions
What is the current share price of NGL Fine Chem Ltd (NGLFINE)?
As of 30 Mar 2026, 12:04 pm IST, NGL Fine Chem Ltd share price is ₹2057.10. The NGLFINE stock has a market capitalisation of ₹833.93 (Cr) on NSE/BSE.
Is NGLFINE share price Overvalued or Undervalued?
NGLFINE share price is currently trading at a P/E ratio of 40.31x, compared to the industry average of 31.77x. Based on this relative valuation, the NGL Fine Chem Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of NGLFINE share price?
The 52-week high of NGLFINE share price is ₹2575.00 and the 52-week low is ₹980.00. These values are updated daily from NSE/BSE price data.
What factors affect the NGL Fine Chem Ltd share price?
Key factors influencing NGLFINE share price include quarterly earnings growth (Sales Growth: 28.65%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is NGL Fine Chem Ltd a good stock for long-term investment?
NGL Fine Chem Ltd shows a 5-year Profit Growth of 16.89% and an ROE of 7.75%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.29 before investing in NGLFINE shares.
How does NGL Fine Chem Ltd compare with its industry peers?
NGL Fine Chem Ltd competes with major peers in the Pharmaceuticals. Investors should compare NGLFINE share price P/E of 40.31x and ROE of 7.75% against the industry averages to determine competitive standing.
What is the P/E ratio of NGLFINE and what does it mean?
NGLFINE share price has a P/E ratio of 40.31x compared to the industry average of 31.77x. Investors pay ₹40 for every ₹1 of annual earnings.
How is NGLFINE performing according to Bull Run's analysis?
NGLFINE has a Bull Run fundamental score of 49/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does NGLFINE belong to?
NGLFINE operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting NGL Fine Chem Ltd share price.
What is Return on Equity (ROE) and why is it important for NGLFINE?
NGLFINE has an ROE of 7.75%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently NGL Fine Chem Ltd generates profits from shareholders capital.
How is NGLFINE debt-to-equity ratio and what does it indicate?
NGLFINE has a debt-to-equity ratio of 0.29, which indicates conservative financing with low financial risk.
What is NGLFINE dividend yield and is it a good dividend stock?
NGLFINE offers a dividend yield of 0.13%, meaning you receive ₹0.13 annual dividend for every ₹100 invested in NGL Fine Chem Ltd shares.
How has NGLFINE share price grown over the past 5 years?
NGLFINE has achieved 5-year growth rates of: Sales Growth 19.41%, Profit Growth 16.89%, and EPS Growth 16.89%.
What is the promoter holding in NGLFINE and why does it matter?
Promoters hold 72.74% of NGLFINE shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in NGL Fine Chem Ltd.
What is NGLFINE market capitalisation category?
NGLFINE has a market capitalisation of ₹834 crores, placing it in the Small-cap category.
How volatile is NGLFINE stock?
NGLFINE has a beta of N/A. A beta > 1 suggests the NGL Fine Chem Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is NGLFINE operating profit margin trend?
NGLFINE has a 5-year average Operating Profit Margin (OPM) of 17.42%, indicating the company's operational efficiency.
How is NGLFINE quarterly performance?
Recent quarterly performance shows NGL Fine Chem Ltd YoY Sales Growth of 28.65% and YoY Profit Growth of -1.83%.
What is the institutional holding pattern in NGLFINE?
NGLFINE has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the NGL Fine Chem Ltd stock.